BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 14678015)

  • 1. The clinical relevance of cytokeratin phenotyping in needle biopsy of liver metastasis.
    Tot T; Samii S
    APMIS; 2003 Dec; 111(12):1075-82. PubMed ID: 14678015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenocarcinomas metastatic to the liver: the value of cytokeratins 20 and 7 in the search for unknown primary tumors.
    Tot T
    Cancer; 1999 Jan; 85(1):171-7. PubMed ID: 9921990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying colorectal metastases in liver biopsies: the novel CDX2 antibody is less specific than the cytokeratin 20+/7- phenotype.
    Tot T
    Med Sci Monit; 2004 May; 10(5):BR139-43. PubMed ID: 15114262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
    Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
    Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of cytokeratins 7 and 20 in determining the origin of metastatic carcinoma of unknown primary, with special emphasis on lung cancer.
    Rubin BP; Skarin AT; Pisick E; Rizk M; Salgia R
    Eur J Cancer Prev; 2001 Feb; 10(1):77-82. PubMed ID: 11263595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary.
    Park SY; Kim HS; Hong EK; Kim WH
    Hum Pathol; 2002 Nov; 33(11):1078-85. PubMed ID: 12454811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of cytokeratins 20 and 7 in discriminating metastatic adenocarcinomas from pleural mesotheliomas.
    Tot T
    Cancer; 2001 Nov; 92(10):2727-32. PubMed ID: 11745209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of distribution of cytokeratins 20 and 7 in special types of invasive breast carcinoma: a study of 123 cases.
    Tot T
    Ann Diagn Pathol; 1999 Dec; 3(6):350-6. PubMed ID: 10594286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of thyroid transcription factor-1, surfacfant protein-B, cytokeratin 7 and cytokeratin 20 in discrimination between primary and metastatic adenocarcinoma of lung].
    Zou SM; Lin DM; Lü N; Liu XY; Wen P; Liu FS
    Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1350-2. PubMed ID: 12930693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of cytokeratins 20 and 7 and estrogen receptor analysis in separation of metastatic lobular carcinoma of the breast and metastatic signet ring cell carcinoma of the gastrointestinal tract.
    Tot T
    APMIS; 2000 Jun; 108(6):467-72. PubMed ID: 11028811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of cytokeratin 7 and cytokeratin 20 expression profile is uniquely associated with tumorigenesis of primary adenocarcinoma of the small intestine.
    Chen ZM; Wang HL
    Am J Surg Pathol; 2004 Oct; 28(10):1352-9. PubMed ID: 15371952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of cytokeratin 7 and 20 for the diagnosis of cerebral metastases of adenocarcinoma: study of 78 cases].
    Fernandez C; Liprandi A; Bouvier-Labit C; Figarella-Branger D
    Ann Pathol; 2001 Apr; 21(2):129-35. PubMed ID: 11373582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoma of Unknown Primary Origin: Application of Immunohistochemistry With Emphasis to Different Cytokeratin 7 and 20 Staining Patterns.
    Mokhtari M; Safavi D; Soleimani N; Monabati A; Safaei A
    Appl Immunohistochem Mol Morphol; 2022 Oct; 30(9):623-634. PubMed ID: 36036642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis.
    Rullier A; Le Bail B; Fawaz R; Blanc JF; Saric J; Bioulac-Sage P
    Am J Surg Pathol; 2000 Jun; 24(6):870-6. PubMed ID: 10843291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma.
    Tot T
    Eur J Cancer; 2002 Apr; 38(6):758-63. PubMed ID: 11937308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokeratin 7 and cytokeratin 20 in primary urinary bladder carcinoma and matched lymph node metastasis.
    Jiang J; Ulbright TM; Younger C; Sanchez K; Bostwick DG; Koch MO; Eble JN; Cheng L
    Arch Pathol Lab Med; 2001 Jul; 125(7):921-3. PubMed ID: 11419977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites.
    Lagendijk JH; Mullink H; Van Diest PJ; Meijer GA; Meijer CJ
    Hum Pathol; 1998 May; 29(5):491-7. PubMed ID: 9596273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokeratin 7 and 20 as immunohistochemical markers in identification of primary tumors in craniospinal metastases: do they have a significant role?
    Taweevisit M; Isarakul P; Chaipipat M; Keetacheeva K; Wattanasirmkit V; Shuangshoti S
    Neuropathology; 2003 Dec; 23(4):271-4. PubMed ID: 14719541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of CK7 and CK20 immunohistochemistry in the detection of synchronous breast and colon carcinoma in a pleural effusion: a case report and supporting survey of archival material.
    Stopyra GA; Warhol MJ; Multhaupt HA
    Diagn Cytopathol; 2001 Jul; 25(1):54-8. PubMed ID: 11466814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma.
    Kennedy MT; Jordan RC; Berean KW; Perez-Ordoñez B
    J Clin Pathol; 2004 Sep; 57(9):932-7. PubMed ID: 15333652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.